Additionally, clinical research has found that ovarian cancer patients commonly exhibit co-enrichment of LPS-producing Gram-negative bacteria in both gut and vaginal microbiota, creating a systemic inflammatory state that promotes tumor metastasis via the IL-6/STAT3 signaling pathway [112], suggesting that the vaginal microbiota promotes tumorigenesis by chronic inflammation activation. The gene discussed is IL6; the disease is ovarian cancer.